Cargando…
Programmed cell death 1‐expressing CD56‐negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment
Dasatinib treatment markedly increases the number of large granular lymphocytes including natural killer (NK) cells in a proportion of Ph(+) leukemia patients, which associates with a better prognosis. In‐depth immune profiling of NK cells can predict therapeutic response in these patients. In the p...
Autores principales: | Ishiyama, Ken‐ichi, Kitawaki, Toshio, Otsuka, Yasuyuki, Takaori‐Kondo, Akifumi, Kadowaki, Norimitsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893985/ https://www.ncbi.nlm.nih.gov/pubmed/33064914 http://dx.doi.org/10.1111/cas.14692 |
Ejemplares similares
-
Cytomegalovirus pulls strings behind NK cells
por: Kadowaki, Norimitsu, et al.
Publicado: (2017) -
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B‐cell lymphoma and enhances T‐cell recruitment
por: Yuan, Hepei, et al.
Publicado: (2021) -
Selection and expansion of natural killer cells for NK cell-based immunotherapy
por: Becker, Petra S. A., et al.
Publicado: (2016) -
High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells
por: Nagano, Seiji, et al.
Publicado: (2019) -
CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)